Arab Drug Balance Sheet Health
Financial Health criteria checks 4/6
Arab Drug has a total shareholder equity of EGP412.0M and total debt of EGP480.0M, which brings its debt-to-equity ratio to 116.5%. Its total assets and total liabilities are EGP1.1B and EGP645.2M respectively. Arab Drug's EBIT is EGP114.8M making its interest coverage ratio 99.4. It has cash and short-term investments of EGP186.4M.
Key information
116.5%
Debt to equity ratio
ج.م479.97m
Debt
| Interest coverage ratio | 99.4x |
| Cash | ج.م186.38m |
| Equity | ج.م411.96m |
| Total liabilities | ج.م645.23m |
| Total assets | ج.م1.06b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ADCI's short term assets (EGP636.9M) exceed its short term liabilities (EGP250.9M).
Long Term Liabilities: ADCI's short term assets (EGP636.9M) exceed its long term liabilities (EGP394.3M).
Debt to Equity History and Analysis
Debt Level: ADCI's net debt to equity ratio (71.3%) is considered high.
Reducing Debt: ADCI's debt to equity ratio has increased from 6.9% to 116.5% over the past 5 years.
Debt Coverage: ADCI's debt is well covered by operating cash flow (32.3%).
Interest Coverage: ADCI's interest payments on its debt are well covered by EBIT (99.4x coverage).